Increased Nanog Expression Promotes Tumor Development and Cisplatin Resistance in Human Esophageal Cancer Cells
Li Yang(Seattle Reproductive Medicine), Lexin Wang(Charles Sturt University), Xiangdong Sun(Guangzhou Design Institute), Yuqiao Sheng(First Affiliated Hospital of Zhengzhou University), Junhui Zhang(Chongqing University), Xudong Zhang(Southern Medical University), Mingzhi Zhang(Chinese Academy of Sciences), Qingjiang Chen(First Affiliated Hospital of Zhengzhou University)
Cited by 39
Related Papers
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
|Frontiers in Immunology|2017|296
Acalabrutinib (ACP-196): a selective second-generation BTK inhibitor
|Journal of Hematology & Oncology|2016|250
Mutations disrupting neuritogenesis genes confer risk for cerebral palsy
|Nature Genetics|2020|174
miR-137 Is Frequently Down-Regulated in Gastric Cancer and Is a Negative Regulator of Cdc42
|Digestive Diseases and Sciences|2011|140
miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy
|Journal of Hematology & Oncology|2018|134